{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T03:38:05Z","timestamp":1706240285434},"reference-count":34,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T00:00:00Z","timestamp":1116892800000},"content-version":"vor","delay-in-days":235,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The issue of continued oral contraceptive use among women with abnormal Pap smears may be controversial due to reported evidence of an increased risk of cervical cancer among long term oral contraceptive users. This article reviews the evidence concerning oral contraception and cervical cancer risk. The role of Human Papilloma virus (HPV)and proposed mechanisms for the development of cervical cancer are explained.Evidence from World Health Organization (WHO) studies and additional research evidence are discussed.Implications for clinical practice are included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources<\/jats:title><jats:p>WHO commissioned studies, additional relevant studies searchable from an EBSCO database, and texts that describe the natural history of HPV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Epidemiological studies and biomedical research suggest a role for steroid hormones, such as oral contraceptives, in facilitating the action of HPV. However, a majority of HPV infections resolve spontaneously, despite widespread use of oral contraception. Oral contraception does not appear to increase incident HPV infection or persistence of HPV infection. The benefits of oral contraceptives appear to outweigh the risks associated with HPV facilitation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications for Practice<\/jats:title><jats:p>NPs inform patients of abnormal Pap smears, manage the clinical care of women at risk of cervical cancer, and provide educational counseling regarding contraceptive choices. Ethical considerations include clear disclosure of potential risk. However, a risk\u2010benefit analysis supports continued use of oral contraception among women who have abnormal Pap smears but also have access to clinical surveillance.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1745-7599.2004.tb00424.x","type":"journal-article","created":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T14:00:40Z","timestamp":1116943240000},"page":"455-461","source":"Crossref","is-referenced-by-count":9,"title":["Evidence for Practice: Oral Contraception and Risk of Cervical Cancer"],"prefix":"10.1111","volume":"16","author":[{"given":"Cathy Cramer","family":"Bertram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,5,24]]},"reference":[{"key":"e_1_2_1_1_2_1","unstructured":"American Cancer Society(2003). www.cancer.org."},{"issue":"6","key":"e_1_2_1_1_3_1","article-title":"Molecular aspects of medicine: The molecular biology of cancer","volume":"21","author":"Bertram J. S.","year":"2000","journal-title":"International Union of Biochemistry and Molecular Biology: Pergamon"},{"issue":"3","key":"e_1_2_1_1_4_1","article-title":"Hormonal contraception and sexually transmitted infections","volume":"23","author":"Best K.","year":"2003","journal-title":"Networks"},{"key":"e_1_2_1_1_5_1","unstructured":"Cox I Buck H. W. Kinney W. &Rubin M. M.(Eds.). (2001).Association of Reproductive Health Professionals clinical proceedings: Human papillomavirus and cervical cancer.Clinical Proceedings: A Publication of Association of Reproductive Health Professionals March.."},{"key":"e_1_2_1_1_6_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1523"},{"issue":"4","key":"e_1_2_1_1_7_1","first-page":"338","article-title":"The natural history of CIN 1 lesions","volume":"19","author":"Duggan M.","year":"1998","journal-title":"European Journal of Gynecologic Oncology"},{"issue":"6","key":"e_1_2_1_1_8_1","first-page":"23","article-title":"Immunohistochemical examinations of dyskeratosis and exocervical neoplasia in gynecologic pathology","volume":"64","author":"Frolova I. I.","year":"2002","journal-title":"Archives of Pathology"},{"key":"e_1_2_1_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600971"},{"key":"e_1_2_1_1_10_1","volume-title":"Contraceptive technology","author":"Hatcher R.","year":"1998"},{"key":"e_1_2_1_1_11_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1779"},{"key":"e_1_2_1_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"issue":"4","key":"e_1_2_1_1_13_1","first-page":"260","article-title":"Oral contraception and cancer: A review of the evidence. Instituto di Ricerche Farmacologiche Mario Negri, Milan, Italy","volume":"14","author":"LaVechia T.","year":"1996","journal-title":"Drug Safety"},{"key":"e_1_2_1_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200303000-00001"},{"key":"e_1_2_1_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08150-3"},{"key":"e_1_2_1_1_16_1","unstructured":"Morrison C. Nanda K. Wong E. et al.(2002 October).Hormonal contraception and incidence and persistence of high\u2010risk human papillomavirus infection. Twentieth International Papillomavirus Conference Paris ."},{"key":"e_1_2_1_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.23.2995"},{"key":"e_1_2_1_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08151-5"},{"issue":"8","key":"e_1_2_1_1_19_1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: Epidemiology and public health","volume":"127","author":"Schiffman M.","year":"2003","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_1_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08125-4"},{"key":"e_1_2_1_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12949-2"},{"key":"e_1_2_1_1_22_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198547969.001.0001","volume-title":"Human papillomaviruses and cervical cancer","author":"Stern P. L.","year":"1994"},{"key":"e_1_2_1_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910550211"},{"key":"e_1_2_1_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04956-4"},{"key":"e_1_2_1_1_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2120"},{"key":"e_1_2_1_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/24.1.19"},{"key":"e_1_2_1_1_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc798"},{"key":"e_1_2_1_2_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/19.1.4"},{"key":"e_1_2_1_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(02)00188-0"},{"key":"e_1_2_1_2_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477"},{"key":"e_1_2_1_2_5_1","unstructured":"Division of Sexually Transmitted Disease Prevention Department of Health and Human Services Centers for Disease Control. (1999 December).Prevention of human papillomavirus infection and sequelae. Report of an External Consultant's Meeting Atlanta GA."},{"key":"e_1_2_1_2_6_1","unstructured":"Family Health International. http:\/\/www.fhi.org\/en\/ReproductiveHealthPublicati ons\/Network\/v22_3\/NWvol122\u20133."},{"key":"e_1_2_1_2_7_1","unstructured":"Family Planning Associates. http:\/\/www.FPA.org.uk\/new\/press\/020325."},{"issue":"3","key":"e_1_2_1_2_8_1","first-page":"42","article-title":"Oral contraceptives, human papillomavirus, and cervical cancer","volume":"23","author":"Rafter N.","year":"2002","journal-title":"Prescriber Update"},{"key":"e_1_2_1_2_9_1","first-page":"817","article-title":"Oral contraception and neoplasia: Report of a World Health Organization scientific group","author":"World Health Organization","year":"1992","journal-title":"World Health Organization Technical Report Series"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2004.tb00424.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2004.tb00424.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2004.tb00424.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T02:39:54Z","timestamp":1706236794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2004.tb00424.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1745-7599.2004.tb00424.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2004.tb00424.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}